Literature DB >> 25944500

Past and current use of walking measures for children with spina bifida: a systematic review.

Derek L Bisaro1, Julia Bidonde1, Kyra J Kane1, Shane Bergsma2, Kristin E Musselman3.   

Abstract

OBJECTIVES: To describe walking measurement in children with spina bifida and to identify patterns in the use of walking measures in this population. DATA SOURCES: Seven medical databases-Medline, PubMed, Embase, Scopus, Web of Science, CINAHL, and AMED-were searched from the earliest known record until March 11, 2014. Search terms encompassed 3 themes: (1) children; (2) spina bifida; and (3) walking. STUDY SELECTION: Articles were included if participants were children with spina bifida aged 1 to 17 years and if walking was measured. Articles were excluded if the assessment was restricted to kinematic, kinetic, or electromyographic analysis of walking. A total of 1751 abstracts were screened by 2 authors independently, and 109 articles were included in this review. DATA EXTRACTION: Data were extracted using standardized forms. Extracted data included study and participant characteristics and details about the walking measures used, including psychometric properties. Two authors evaluated the methodological quality of articles using a previously published framework that considers sampling method, study design, and psychometric properties of the measures used. DATA SYNTHESIS: Nineteen walking measures were identified. Ordinal-level rating scales (eg, Hoffer Functional Ambulation Scale) were most commonly used (57% of articles), followed by ratio-level, spatiotemporal measures, such as walking speed (18% of articles). Walking was measured for various reasons relevant to multiple health care disciplines. A machine learning analysis was used to identify patterns in the use of walking measures. The learned classifier predicted whether a spatiotemporal measure was used with 77.1% accuracy. A trend to use spatiotemporal measures in older children and those with lumbar and sacral spinal lesions was identified. Most articles were prospective studies that used samples of convenience and unblinded assessors. Few articles evaluated or considered the psychometric properties of the walking measures used.
CONCLUSIONS: Despite a demonstrated need to measure walking in children with spina bifida, few valid, reliable, and responsive measures have been established for this population.
Copyright © 2015 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Rehabilitation; Review; Spinal dysraphism; Walking

Mesh:

Year:  2015        PMID: 25944500     DOI: 10.1016/j.apmr.2015.04.014

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  5 in total

1.  Current state of balance assessment during transferring, sitting, standing and walking activities for the spinal cord injured population: A systematic review.

Authors:  Tarun Arora; Alison Oates; Kaylea Lynd; Kristin E Musselman
Journal:  J Spinal Cord Med       Date:  2018-06-05       Impact factor: 1.985

2.  Walking activity during daily living in children with myelomeningocele.

Authors:  Pauline Yasmeh; Nicole M Mueske; Siamak Yasmeh; Deirdre D Ryan; Tishya A L Wren
Journal:  Disabil Rehabil       Date:  2016-07-06       Impact factor: 3.033

Review 3.  Scoping Review of Judgment-Based Measures of Ambulation with Assistive Devices for Children and Youth.

Authors:  Helene M Dumas; Maria A Fragala-Pinkham; Richard Moed
Journal:  Phys Occup Ther Pediatr       Date:  2020-05-18       Impact factor: 2.360

4.  Preliminary study of novel, timed walking tests for children with spina bifida or cerebral palsy.

Authors:  Kyra J Kane; Joel Lanovaz; Derek Bisaro; Alison Oates; Kristin E Musselman
Journal:  SAGE Open Med       Date:  2016-07-11

5.  Myelomeningocele: a new functional classification.

Authors:  Luciano S Dias; Vineeta T Swaroop; Luiz R A de Angeli; Jill E Larson; Ana-Marie Rojas; Tasos Karakostas
Journal:  J Child Orthop       Date:  2021-02-01       Impact factor: 1.548

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.